A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

April 12, 2026

Study Completion Date

April 12, 2026

Conditions
Lupus
Interventions
DRUG

BMS-986326

Specified dose on specified days

OTHER

Placebo for BMS-986326

Specified dose on specified days

Trial Locations (27)

1430

RECRUITING

Clinica Adventista Belgrano, CABA

1618

ACTIVE_NOT_RECRUITING

Local Institution - 0072, Sofia

1629

RECRUITING

Hospital Universitario Austral, Pilar

10032

WITHDRAWN

Columbia University Irving Medical Center, New York

10117

RECRUITING

Charité Research Organisation, Berlin

11658

RECRUITING

ARENSIA Exploratory Medicine, Bucharest

14004

RECRUITING

Hospital Universitario Reina Sofia, Córdoba

15006

RECRUITING

CHUAC-Complejo Hospitalario Universitario A Coruña, A Coruña

16635

RECRUITING

Altoona Center For Clinical Research, Duncansville

30046

WITHDRAWN

North Georgia Rheumatology, Lawrenceville

31217

WITHDRAWN

Local Institution - 0077, Chihuahua City

33606

RECRUITING

Clinical Research of West Florida, Tampa

33765

RECRUITING

Clinical Research of West Florida, Inc. (Clearwater), Clearwater

40217

RECRUITING

Skin Sciences, Louisville

75013

WITHDRAWN

Allen Arthritis, Allen

75231

WITHDRAWN

Metroplex Clinical Research Center, Dallas

89102

COMPLETED

Local Institution - 0062, Las Vegas

92108

COMPLETED

Local Institution - 0048, San Diego

99204

RECRUITING

Arthritis Northwest, PLLC, Spokane

400006

RECRUITING

ARENSIA Exploratory Medicine, Cluj-Napoca

06847

RECRUITING

Städtisches Klinikum Dessau, Dessau

01307

RECRUITING

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden

06100

WITHDRAWN

Local Institution - 0073, Cuauhtémoc, Ciudad de México

07760

WITHDRAWN

Local Institution - 0068, Mexico City

2333 CL

COMPLETED

Local Institution - 0051, Leiden

02-953

RECRUITING

Klinika Ambroziak Dermatologia, Warsaw

61-848

RECRUITING

Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06013995 - A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus | Biotech Hunter | Biotech Hunter